skip to content

Clinical Neurosciences

 
Gita Khalili Moghaddam copyright University of Cambridge

Gita Khalili Moghaddam has been named one of the top 13 women changemakers in the UK by the Royal Society. The award was given for the translational impact of her research and entrepreneurial activities. This work originated during her PhD at Cambridge under the supervision of Prof Chris Lowe and was been supported by Cambridge Enterprise.

Leveraging artificial intelligence (AI) to push the boundaries of diagnostics has led Gita Khalili Moghaddam to establish several spinout companies, including GlycoVue. Whilst currently in the prototype phase, Gita’s spinout companies aim to improve existing diagnostic methods that can take weeks to provide answers. 

Currently a Royal Society Industry Fellow, Gita splits her time between being a Principal Investigator at the University of Cambridge and undertaking her Industry Fellowship. The focus of her fellowship is to utilise similar artificial intelligence technologies to those used in GlycoVue to improve diagnostic pathways for tuberculosis. A recent breakthrough saw Gita and her team identify new image biomarkers which will work to identify Tuberculosis with greater accuracy.

Read the full interview with Gita provided to the Royal Society in their publication 'Meet the Changemakers'.